Posts

From ex vivo to in vivo: Shaping the next generation of viral vector manufacturing – Recent industry trends and challenges

on

FDA panel to review Grail's blood‑based multi‑cancer early detection test

on

Trump signs executive order to overhaul pediatric vaccine recommendations

on

Epicrispr secures $90M after early data on epigenetic FSHD treatment | 2026-08-11

on

AbbVie, Novartis and Bristol Myers Squibb Sue Illinois Over 340B Contract Pharmacy Law

on

Lilly's $3.8B vaccine biotech spree and Infinimmune's $75M raise

on

Ying Huang's post-Legend Life Takes Shape at K2 With $250M Goal to License Asia Assets

on

Rare Disease Drugmakers Watch FDA for Renewed Focus on Therapies

on

Phase II win for Silence's divesiran in PV lifts bar for Takeda's rusfertide

on

Trump signs executive order to overhaul pediatric vaccine recommendations – August 2026

on

Recent News: "The Agentic Test" Webinar Explores Whether Agentic AI Can Accelerate Drug Development and Break Down Pharma Silos

on

Unapproved in US for decades, levosimendan stumbles in phase 3 as Tenax eyes narrow FDA path

on

Epicrispr raises $90M to rewrite treatment of rare muscle disease

on